SOLARA — Solara Active Pharma Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹18.39bn
- IN₹26.21bn
- IN₹12.84bn
- 65
- 36
- 59
- 55
Annual cashflow statement for Solara Active Pharma Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,215 | -911 | -448 | -4,884 | 5.4 |
| Depreciation | |||||
| Non-Cash Items | 645 | 686 | 756 | 1,796 | 1,109 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,392 | -3,319 | 143 | 3,143 | 21.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,555 | -2,420 | 1,563 | 1,089 | 2,128 |
| Capital Expenditures | -1,745 | -2,086 | -1,113 | -411 | -399 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 682 | -342 | 302 | 376 | 31.1 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,063 | -2,429 | -811 | -35.1 | -368 |
| Financing Cash Flow Items | -832 | -734 | -875 | -1,026 | -1,160 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 925 | 3,336 | -1,128 | -1,057 | -1,805 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,417 | -1,513 | -377 | -2.9 | -44.9 |